Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Auriga Maintains a 'Buy' on Altera (ALTR); Near term Weakness but Longer Term Trends Intact
-
Auriga Maintains a 'Buy' on Xilinx (XLNX); Strong Beat, Inline Guide despite Gross Margin Headwinds
-
Auriga Maintains a 'Buy' on Xilinx (XLNX); Wireless Driven Top-line Growth Offsets Opex Uptick
-
Notable Analyst Rating Changes 04/13: (GTXI) (ALTR) (IRBT) Upgraded; (SUN) (MT) (LEDS) Downgraded
-
Auriga Assumes Coverage on Xilinx (XLNX) at Buy; Near-Term Risk, but Longer-Term Prospects Remain Attractive
-
Auriga Maintains a 'Buy' on Xilinx (XLNX); Analyst Day Increases Our Conviction in 28nm Potential
-
Auriga Prefers Xilinx's (XLNX) Over Altera (ALTR) on Valuation and Potential Operating Leverage
-
Notable Analyst Rating Changes 01/25: CSX, ION, XLNX, RKT Higher; ADBE, GNK, NSC, TLAB Lower
-
Daily State of the Markets 01/25: Back In The Saddle?
-
Auriga Upgrades Xilinx (XLNX) to Buy, Price Target $37
-
Auriga Changes 2011 Estimates on Xilinx (XLNX), Maintains Hold Rating
-
Auriga Raises Estimates & Price Target on Xilinx (XLNX), Maintains Hold Rating
-
Auriga Maintains a 'Hold' on Xilinx (XLNX); Weakness Likely Driven by Inventory Correction in Wireless
-
Auriga Starts Xilinx Corp (XLNX) at Hold, Citing Wireline Weakness and Potential Share Loss
